Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P44
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -10.63% |
| Q3 2025 | -10.10% |
| Q2 2025 | -11.03% |
| Q1 2025 | -9.61% |
| Q4 2024 | -9.44% |
| Q3 2024 | -1.74% |
| Q2 2024 | -2.64% |
| Q1 2024 | 11.08% |
| Q4 2023 | 33.74% |
| Q3 2023 | -12.15% |
| Q2 2023 | -14.35% |
| Q1 2023 | 248.75% |
| Q4 2022 | -26.14% |
| Q3 2022 | 31.77% |
| Q2 2022 | -21.17% |
| Q1 2022 | -20.63% |
| Q4 2021 | 7.91% |
| Q3 2021 | -20.78% |
| Q2 2021 | -19.40% |
| Q1 2021 | -12.19% |
| Q4 2020 | -6.89% |
| Q3 2020 | 114.98% |
| Q2 2020 | -3.77% |
| Q1 2020 | -20.12% |
| Q4 2019 | -8.59% |
| Q3 2019 | -8.63% |
| Q2 2019 | 7.12% |
| Q1 2019 | 110.13% |
| Q4 2018 | -29.48% |
| Q3 2018 | -20.65% |
| Q2 2018 | -17.04% |
| Q1 2018 | -32.40% |
| Q4 2017 | 40.58% |
| Q3 2017 | -19.75% |
| Q2 2017 | -14.70% |
| Q1 2017 | -10.66% |
| Q4 2016 | -9.40% |
| Q3 2016 | -4.78% |
| Q2 2016 | -5.40% |
| Q1 2016 | -3.80% |